Study links gut bacteria infection to Alzheimer’s disease progression

A groundbreaking study by researchers at Florida State University’s Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer’s disease.

First Therapy Approved for Ultra-Rare Bone Disorder

The FDA approved the oral retinoid palovarotene (Sohonos) for treating abnormal bone growth associated with fibrodysplasia ossificans progressiva (FOP), drugmaker Ipsen announced on Wednesday. Palovarotene,

August 17, 2023

Loneliness may not be a direct cause of disease

A study reveals loneliness correlates with 13 illness categories, highlighting its role as a potential proxy marker rather than a direct risk factor.

September 17, 2024

Labcorp expands Alzheimer’s blood tests for doctors and drugmakers

A simple blood test that predicts whether a person is likely to have Alzheimer’s disease is now available to doctors and drugmakers. Labcorp, one of

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.